Treatment of rheumatoid arthritis with rituximab: an update and possible indications.

Abstract:

:Based on new biologic and clinical insights, the number of drugs blocking different biologic targets in rheumatoid arthritis (RA) [e.g., tumor necrosis factor alpha (TNFalpha), CTLA4, interleukin (IL)-1, IL-6, IL-15, IL-18, B lymphocyte stimulator (BLyS), CD20] has increased considerably over the last decade. Rituximab, a chimeric monoclonal antibody that was developed for the treatment of B-cell lymphomas, has been used in different autoimmune diseases where B-cells are thought to play a pivotal role. However, blinded randomised controlled trials have been completed only for RA so far, indicating the clear efficacy of B-cell blockade in RA and highlighting the pathogenetic B-cell in rheumatoid synovitis. The use of rituximab in RA is herein updated, from early preliminary studies to more recent presentations in International Conferences. Key clinical and biologic issues are discussed, i.e., efficacy and safety of rituximab, role of concomitant therapies, use in the long term and retreatment strategies, differences with anti-TNFalpha therapy. The possible indications in RA are finally discussed, also on the ground of personal experience with rituximab in RA and other rheumatic diseases associated with B-cell lymphoproliferation. Further clinical research should go hand in hand with laboratory research, and tissue studies are now needed.

journal_name

Autoimmun Rev

journal_title

Autoimmunity reviews

authors

De Vita S,Quartuccio L

doi

10.1016/j.autrev.2006.02.007

subject

Has Abstract

pub_date

2006-08-01 00:00:00

pages

443-8

issue

7

eissn

1568-9972

issn

1873-0183

pii

S1568-9972(06)00024-3

journal_volume

5

pub_type

杂志文章,评审
  • Role of MHC Class II genes in the pathogenesis of pemphigoid.

    abstract::Pemphigoid (Pg) is an autoimmune subepidermal blistering disease that affects the elderly population. The phenotype can be Bullous Pemphigoid (BP), which primarily involves the skin, or Mucous Membrane Pemphigoid (MMP), which primarily involves mucus membranes. Ocular Cicatricial Pemphigoid (OCP) and Oral Pemphigoid (...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.07.002

    authors: Zakka LR,Reche P,Ahmed AR

    更新日期:2011-11-01 00:00:00

  • Idiopathic aplastic anemia: diagnosis and classification.

    abstract::Aplastic anemia (AA) is a disease characterized by pancytopenia and hypoplastic bone marrow caused by the decrease of hematopoietic stem cells. The pathogenesis of AA is complex and involves an abnormal hematopoietic microenvironment, hematopoietic stem cell/progenitor cell deficiencies and immunity disorders. Surviva...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.01.014

    authors: Dolberg OJ,Levy Y

    更新日期:2014-04-01 00:00:00

  • New insights into the pathogenesis of Behçet's disease.

    abstract::Behçet's disease (BD) is a recurrent systemic inflammatory disorder of unknown origin characterized by oral and genital mucous ulcer, uveitis, and skin lesions. Involvement of large vessels, central nervous system (CNS), gastrointestinal tract and thrombotic events are less frequent but can be life threatening. The ai...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.11.026

    authors: Pineton de Chambrun M,Wechsler B,Geri G,Cacoub P,Saadoun D

    更新日期:2012-08-01 00:00:00

  • Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis: A systematic literature review.

    abstract:OBJECTIVE:We investigated the effectiveness of rituximab (an anti-CD20 monoclonal antibody) in patients with eosinophilic granulomatosis with polyangiitis (EGPA). METHODS:We performed a systematic literature review from the inception dates until July 20, 2020 for articles reporting rituximab administration to treat EG...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2020.102737

    authors: Akiyama M,Kaneko Y,Takeuchi T

    更新日期:2021-02-01 00:00:00

  • X chromosome monosomy in primary and overlapping autoimmune diseases.

    abstract::Female predominance is a common characteristic for autoimmune diseases attributed to the combined effect of hormonal influence and genetic factors. Since X chromosome has immunologically important genes, the age related X chromosome loss could contribute to the development of autoimmunity. X chromosome monosomy (XCM) ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.03.001

    authors: Svyryd Y,Hernández-Molina G,Vargas F,Sánchez-Guerrero J,Segovia DA,Mutchinick OM

    更新日期:2012-03-01 00:00:00

  • CD28 superagonists put a break on autoimmunity by preferentially activating CD4+CD25+ regulatory T cells.

    abstract::There is strong evidence that a quantitative and/or functional deficiency in CD4+CD25+ regulatory T cells (T(reg) cells) plays a key role in the pathogenesis of many human autoimmune diseases. Therefore, targeting regulatory T cells with novel forms of immunotherapy should provide a means for successfully battling aut...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2005.06.001

    authors: Beyersdorf N,Hanke T,Kerkau T,Hünig T

    更新日期:2006-01-01 00:00:00

  • New genetic interpretation of old diseases.

    abstract::The title of this section, "New genetic interpretation of old diseases," perfectly reflects the unique history of our understanding of autoinflammatory diseases (AIDs). Indeed, the main clinical feature of most AIDs is the recurrent fever, a symptom that has been extensively documented for centuries. However, the firs...

    journal_title:Autoimmunity reviews

    pub_type: 历史文章,杂志文章,评审

    doi:10.1016/j.autrev.2012.07.014

    authors: Touitou I

    更新日期:2012-11-01 00:00:00

  • Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature.

    abstract:OBJECTIVES:To assess the efficacy and safety of Rituximab (RTX) in adult primary central nervous system vasculitis (PCNSV). METHODS:We retrospectively assessed the effect of RTX in 6 patients with PCNSV. Five of the 6 were refractory to high dose glucocorticoids (GCs) and/or conventional immunosuppressants (IS). The s...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.12.002

    authors: Salvarani C,Brown RD Jr,Muratore F,Christianson TJH,Galli E,Pipitone N,Cassone G,Huston J III,Giannini C,Warrington K,Hunder GG

    更新日期:2019-04-01 00:00:00

  • Is there a crossroad between infections, genetics, and Henoch-Schönlein purpura?

    abstract::Henoch-Schönlein purpura is the most common systemic vasculitis in childhood, characterized by the presence of immunoglobulin A deposits in the small vessels of skin, gastrointestinal tube, joints and kidneys. Although there have been great efforts made in elucidating its pathogenic mechanisms, Henoch-Schönlein purpur...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2013.04.003

    authors: Rigante D,Castellazzi L,Bosco A,Esposito S

    更新日期:2013-08-01 00:00:00

  • Enteropathic spondyloarthritis: Results from a large nationwide database analysis.

    abstract:INTRODUCTION:Spondyloarthrits (SpA) share clinical, genetic and immunological features with Inflammatory Bowel Diseases (IBD), and enteropathic SpA (eSpA) represent the clinical evidence of the association between gut and joint diseases. This cross-sectional study aimed to report data of eSpA patients collected from th...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2019.102457

    authors: Picchianti-Diamanti A,Lorenzetti R,Chimenti MS,Luchetti MM,Conigliaro P,Canofari C,Benfaremo D,Bruzzese V,Laganà B,Perricone R,SIGR.

    更新日期:2020-02-01 00:00:00

  • "How I treat" autoimmune diseases: State of the art on the management of rare rheumatic diseases and ANCA-associated systemic idiopathic vasculitis.

    abstract::This Special Issue of Autoimmunity Reviews constitutes summaries of presentations at the 20th International Meeting on Immunopathology and Orphan Diseases, held in Torino, Italy, 25-28th January 2017. As such, these presentations represent the state of the art on the pathophysiology of autoimmune diseases as well as t...

    journal_title:Autoimmunity reviews

    pub_type: 社论

    doi:10.1016/j.autrev.2017.07.015

    authors: Roccatello D

    更新日期:2017-10-01 00:00:00

  • Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis.

    abstract::Antineutrophil cytoplasmic antibodies (ANCA) are the serological hallmark of some idiopathic systemic vasculitides, such as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and, to a lesser extent, Churg-Strauss syndrome (CCS), the so-called ANCA-associated vasculitides (AAV). ANCA were first det...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2012.08.008

    authors: Radice A,Bianchi L,Sinico RA

    更新日期:2013-02-01 00:00:00

  • Diagnosis and classification of pernicious anemia.

    abstract::Pernicious anemia (PA) is a complex disorder consisting of hematological, gastric and immunological alterations. Diagnosis of PA relies on histologically proven atrophic body gastritis, peripheral blood examination showing megaloblastic anemia with hypersegmented neutrophils, cobalamin deficiency and antibodies to int...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.01.042

    authors: Bizzaro N,Antico A

    更新日期:2014-04-01 00:00:00

  • Improving the effectiveness of autoantibody testing in the clinic.

    abstract::To enable clinicians to use autoantibody tests sensibly and economically, laboratories providing the test service have a responsibility to supply the test 'specifications'. This should include information about the test's validity and reliability, its normal range or range within a control population, its sensitivity ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s1568-9972(02)00061-7

    authors: Sturgess A,Edmonds J

    更新日期:2002-10-01 00:00:00

  • Prednisone in lupus nephritis: how much is enough?

    abstract:OBJECTIVE:To assess the effectiveness and safety of a protocol using medium doses of prednisone to treat lupus nephritis. METHODS:Patients receiving the 'Cruces-protocol cohort' (CPC) were paired 1:2 with patients from the 'historic cohort' (HC). The CPC received medium doses of prednisone combined with methyl-prednis...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2013.10.013

    authors: Ruiz-Irastorza G,Danza A,Perales I,Villar I,Garcia M,Delgado S,Khamashta M

    更新日期:2014-02-01 00:00:00

  • Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation.

    abstract::A few scores predicting the short-term risk of mortality in Systemic sclerosis (SSc) have been reported to date. Our study aimed to create a predictive 15-year all-cause mortality score at the time of the diagnosis of SSc. The study was based on the Spanish Scleroderma Registry (RESCLE). The cohort was split up in der...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2020.102507

    authors: Rubio-Rivas M,Corbella X,Guillén-Del-Castillo A,Tolosa Vilella C,Colunga Argüelles D,Argibay A,Vargas Hitos JA,Todolí Parra JA,González-Echávarri C,Ortego-Centeno N,Trapiella Martínez L,Rodríguez Carballeira M,Marín Ballvé A,Pl

    更新日期:2020-05-01 00:00:00

  • The mosaic of B-cell subsets (with special emphasis on primary Sjögren's syndrome).

    abstract::Major breakthroughs have occurred with classification of B-cells into populations and subpopulations. With respect to their expression of CD5, they comprise the B1 and B2 populations, with the former further divided into B1a and B1b subpopulations. The oncologic process starts from transitional type 1 (T1) and T2 imma...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2006.09.011

    authors: Le Pottier L,Devauchelle V,Pers JO,Jamin C,Youinou P

    更新日期:2007-01-01 00:00:00

  • Environmental risk factors associated with ANCA associated vasculitis: A systematic mapping review.

    abstract:BACKGROUND:Anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) is a rare multi-system autoimmune disease, characterised by a pauci-immune necrotising small-vessel vasculitis, with a relapsing and remitting course. Like many autoimmune diseases, the exact aetiology of AAV, and the factors that influenc...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2020.102660

    authors: Scott J,Hartnett J,Mockler D,Little MA

    更新日期:2020-11-01 00:00:00

  • Menopause in patients with autoimmune diseases.

    abstract::Menopause represents a time of significant clinical and hormonal change. Given the incompletely understood interrelationship between gonadal hormones and the immune system, it is possible that menopause may affect, or be affected by, the presence of autoimmune disease. Menopause has significant effects on a number of ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.11.006

    authors: Sammaritano LR

    更新日期:2012-05-01 00:00:00

  • A comprehensive analysis of treatment outcomes in patients with pemphigus vulgaris treated with rituximab.

    abstract::Approximately 500 treatment recalcitrant pemphigus vulgaris patients have been treated with rituximab. They were treated according to the lymphoma protocol (N=224) or rheumatoid arthritis protocol (RAP) (N=209) patients. Others were treated with modifications or combinations of the two. The mean duration of follow-up ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.12.002

    authors: Ahmed AR,Shetty S

    更新日期:2015-04-01 00:00:00

  • Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

    abstract:BACKGROUND:According to criteria for the classification of Systemic Lupus Erythematosus (SLE), thrombocytopenia is one of the disease-defining hematologic disorders. Since the recognition of Antiphospholipid Syndrome (APS), thrombocytopenia was frequently reported but several studies yielded contradictory results on th...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.autrev.2019.102395

    authors: Chock YP,Moulinet T,Dufrost V,Erkan D,Wahl D,Zuily S

    更新日期:2019-11-01 00:00:00

  • Pathogenesis of hemophagocytic syndrome (HPS).

    abstract::Hemophagocytic syndrome (HPS) is a clinicopathologic entity characterized by increased proliferation and activation of benign macrophages with hemophagocytosis throughout the reticuloendothelial system. Uncontrolled T-lymphocyte activation is responsible for increased T(H)1 cytokines secretion such as IFN-gamma, IL-12...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/S1568-9972(03)00091-0

    authors: Larroche C,Mouthon L

    更新日期:2004-02-01 00:00:00

  • Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases.

    abstract::Rituximab is a monoclonal antibody directed against the CD20 antigen expressed on B cells and widely used in the treatment of non-Hodgkin's lymphoma and rheumatoid arthritis. There is a growing amount of literature which suggests that rituximab may be useful for inflammatory ocular diseases and intraocular lymphoma. F...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.07.001

    authors: Miserocchi E,Pontikaki I,Modorati G,Gattinara M,Meroni PL,Gerloni V

    更新日期:2011-11-01 00:00:00

  • Biosimilars from a practicing rheumatologist perspective: An overview.

    abstract::The earliest experimental trials of monoclonal antibodies took place in the early 1980s using murine monoclonal antibodies directed at human lymphoma and leukemia cell antigens. Since those early trials, therapeutic advances have produced monoclonal antibodies and fusion proteins that are now used in multiple disease ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.07.001

    authors: Schimizzi GF

    更新日期:2016-09-01 00:00:00

  • Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases.

    abstract:OBJECTIVE:To describe the clinical and immunologic features of 6 patients with rheumatic disease and Hepatitis C Virus (HCV) chronic infection, treated with anti-TNF alpha drugs. PATIENTS AND METHODS:Six patients, with repeated positive serology for HCV infection, were affected by Rheumatoid arthritis (RA) (4 cases), ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2008.05.002

    authors: Cavazzana I,Ceribelli A,Cattaneo R,Franceschini F

    更新日期:2008-12-01 00:00:00

  • Pulmonary manifestations in antiphospholipid syndrome.

    abstract::Pulmonary manifestations in antiphospholipid syndrome (APS) are relatively rare compared to other clinical signs of this disease. However, pulmonary microthrombosis is among the most frequent arterial complications of APS. Timely diagnosis of pulmonary manifestations is required due both to their severity and to the h...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2006.02.002

    authors: Stojanovich L

    更新日期:2006-05-01 00:00:00

  • Neonatal lupus: Follow-up in infants with anti-SSA/Ro antibodies and review of the literature.

    abstract::Neonatal Lupus Syndrome (NLS) is a distinct clinical entity caused by transplacental passage of maternal anti-SSA/Ro antibodies (Ab). Mothers may have systemic lupus erythematosus, Sjögren syndrome, or other connective tissue disease, or may be completely healthy at the time of giving birth. NLS includes several clini...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.02.010

    authors: Zuppa AA,Riccardi R,Frezza S,Gallini F,Luciano RM,Alighieri G,Romagnoli C,De Carolis S

    更新日期:2017-04-01 00:00:00

  • The role of nailfold capillaroscopy in the assessment of internal organ involvement in systemic sclerosis: A critical review.

    abstract::Endothelial dysfunction and microvascular damage constitute the hallmarks of systemic sclerosis (SSc), explaining much of the pathophysiology and clinical manifestations of the disease. Nailfold videocapillaroscopy (NVC) is an established method for the assessment of the microvasculature, aiding in distinguishing diff...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.05.019

    authors: Soulaidopoulos S,Triantafyllidou E,Garyfallos A,Kitas GD,Dimitroulas T

    更新日期:2017-08-01 00:00:00

  • Alpha-actinin: a multidisciplinary protein with important role in B-cell driven autoimmunity.

    abstract::Alpha-actinin (α-actinin) is a ubiquitous cytoskeletal protein, which belongs to the superfamily of filamentous actin (F-actin) crosslinking proteins. It is present in multiple subcellular regions of both muscle and non-muscle cells, including cell-cell and cell-matrix contact sites, cellular protrusions and stress fi...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2010.12.009

    authors: Oikonomou KG,Zachou K,Dalekos GN

    更新日期:2011-05-01 00:00:00

  • Catastrophic antiphospholipid (Asherson's) syndrome and genetic thrombophilic disorders in obstetrics.

    abstract::Catastrophic antiphospholipid syndrome (CAPS) (Asherson's Syndrome), is a life-threatening condition characterized by a rapidly progressive thromboses resulting in a multiorgan dysfunction syndrome (MODS), evidence of systemic inflammatory response syndrome (SIRS) in the presence of antiphospholipid antibodies. CAPS d...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2006.06.011

    authors: Makatsariya A,Asherson RA,Bitsadze V,Baimuradova S,Akinshina S

    更新日期:2006-12-01 00:00:00